Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Scientists at Takeda present new mTOR inhibitors for cancer and other disorders

March 18, 2011

U.S. researchers synthesize novel 15-LOX inhibitors

March 18, 2011

Modulators of cell cycle checkpoints patented by Merck & Co.

March 18, 2011

Oncolytic herpes simplex virus safe and feasible in patients with advanced pancreatic cancer

March 18, 2011

Preclinical antitumor activity reported for (R)-bicalutamide derivatives ISIR-9 and ISIR-11

March 18, 2011

Scientists at Novartis and IRM present novel B-raf inhibitors

March 18, 2011

Cytavis begins recruitment in Austria for phase II trial of CY-503 in colorectal carcinoma

March 17, 2011

Human Genome Sciences acquires rights to anticancer drug FP-1039 from FivePrime

March 17, 2011

PsiOxus begins phase II study of MT-102 in cachexia

March 17, 2011

Array BioPharma and Genentech patent new B-raf inhibitors for cancer

March 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...